Dendritic-cell interactions with HIV: Infection and viral dissemination

Nature Reviews Immunology

Volumn 6, Issue 11, 2006, Pages 859-868

  Wu, Li ^a   KewalRamani, Vineet N ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6;

CD4+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARY FOLLICLE CELL; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; DENDRITIC CELLS; HIV; HIV INFECTIONS; HUMANS; LECTINS, C-TYPE; RECEPTORS, CELL SURFACE; VIRUS INTERNALIZATION;

EID: 33750378183     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1960     Document Type: Review

References (128)

1. United Nations Programme on HIV/AIDS. 2006 Report on the Global AIDS epidemic 8 (UNAIDS, Geneva, 2006).
2. Shattock, R. J. & Moore, J. P. Inhibiting sexual transmission of HIV-1 infection. Nature. Rev. Microbiol. 1, 25-34 (2003).
3. Pope, M. & Haase, A. T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nature Med. 9, 847-852 (2003).
4. Steinman, R. M. et al. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276, 1-30 (2003).
5. Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783-792 (2005).
6. + T cells. Science 257, 383-387 (1992).
7. Pope, M. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994).
8. McDonald, D. et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300, 1295-1297 (2003). First paper to describe infectious synapses between DCs and T cells.
9. Arrighi, J. F. et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279-1288 (2004).
10. Wiley, R. D. & Gummuluru, S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl Acad. Sci. USA 103, 738-743 (2006). Recent paper that describes HIV trans-infection mediated by exosome release from immature MDDCs.
11. Kawamura, T. et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl Acad. Sci. USA 100, 8401-8406 (2003).
12. Turville, S. G. et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103, 2170-2179 (2004). Reports the rapid transmission and long-term transmission of HIV by human MDDCs.
13. Nobile, C. et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79, 5386-5399 (2005).
14. + T cells. J. Exp. Med. 201, 2023-2033 (2005).
15. Burleigh, L. et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80, 2949-2957 (2006).
16. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
17. Liu, Y. J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-262 (2001).
18. Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186 (1999).
19. Cella, M. et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Med. 5, 919-923 (1999).
20. Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
21. Zaitseva, M. et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med. 3, 1369-1375 (1997).
22. Valladeau, J. et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29, 2695-2704 (1999).
23. Niedecken, H., Lutz, G., Bauer, R. & Kreysel, H. W. Langerhans cell as primary target and vehicle for transmission of HIV. Lancet 2, 519-520 (1987).
24. Berger, R. et al. Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. J. Invest. Dermatol. 99, 271-277 (1992).
25. Soto-Ramirez, L. E. et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 271, 1291-1293 (1996).
26. + T lymphocytes results in altered T cell responses with enhanced production of IFN-γ and IL-10. Virology 215, 51-60 (1996).
27. Blauvelt, A. et al. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 100, 2043-2053 (1997).
28. Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W. & Steinman, R. M. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72, 2733-2737 (1998).
29. Granelli-Piperno, A., Finkel, V., Delgado, E. & Steinman, R. M. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9, 21-29 (1999).
30. Kawamura, T. et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 192, 1491-1500 (2000).
31. Patterson, S., Rae, A., Hockey, N., Gilmour, J. & Gotch, F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75, 6710-6713 (2001).
32. - plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98, 2574-2576 (2001).
33. Smed-Sorensen, A. et al. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 79, 8861-8869 (2005).
34. Granelli-Piperno, A. et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 184, 2433-2438 (1996).
35. Rubbert, A. et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J. Immunol. 160, 3933-3941 (1998).
36. Turville, S. G. et al. HIV gp120 receptors on human dendritic cells. Blood 98, 2482-2488 (2001).
37. Ignatius, R. et al. The immunodeficiency virus coreceptor, Bonzo/STRL33/TYMSTR, is expressed by macaque and human skin- and blood-derived dendritic cells. AIDS Res. Hum. Retroviruses 16, 1055-1059 (2000).
38. Beaulieu, S. et al. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells. J. Immunol. 169, 2925-2936 (2002).
39. + T cells clonal expansion. Clin. Exp. Immunol. 88, 226-236 (1992).
40. + T cells. J. Exp. Med. 182, 2045-2056 (1995).
41. + T lymphocytes in spleens of human immunodeficiency virus-positive patients. J. Virol. 69, 4737-4745 (1995).
42. Moris, A. et al. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103, 2648-2654 (2004).
43. + T cells. Nature 435, 108-114 (2005).
44. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
45. Tenner-Racz, K. et al. Immunohistochemical, electron microscopic and in situ hybridization evidence for the involvement of lymphatics in the spread of HIV-1. AIDS 2, 299-309 (1988).
46. Heath, S. L., Tew, J. G., Szakal, A. K. & Burton, G. F. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377, 740-744 (1995).
47. Burton, G. F., Keele, B. F., Estes, J. D., Thacker, T. C. & Gartner, S. Follicular dendritic cell contributions to HIV pathogenesis. Semin. Immunol. 14, 275-284 (2002).
48. Schacker, T. et al. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J. Infect. Dis. 181, 354-357 (2000).
49. + T-helper cells. Am. J. Pathol. 140, 15-22 (1992).
50. Smith, B. A. et al. Persistence of infectious HIV on follicular dendritic cells. J. Immunol. 166, 690-696 (2001).
51. Popov, S., Chenine, A. L., Gruber, A., Li, P. L. & Ruprecht, R. M. Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells. J. Virol. 79, 602-608 (2005).
52. Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93 (1994).
53. Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000). First paper to identify DC-SIGN.
54. H cell-polarizing signals. J. Immunol. 168, 1704-1709 (2002).
55. Sanders, R. W. et al. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76, 7812-7821 (2002).
56. Turville, S. G. et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol. 3, 975-983 (2002). Characterizes a variety of HIV-binding receptors expressed by DC subsets.
57. Jefford, M. et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102, 1753-1763 (2003).
58. Granelli-Piperno, A. et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175, 4265-4273 (2005). Reports that DC-SIGN is not required for DCs to transmit HIV and stimulate T cells.
59. Macatonia, S. E., Lau, R., Patterson, S., Pinching, A. J. & Knight, S. C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71, 38-45 (1990).
60. Knight, S. C., Patterson, S. & Macatonia, S. E. Stimulatory and suppressive effects of infection of dendritic cells with HIV-1. Immunol. Lett. 30, 213-218 (1991).
61. + dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 16, 683-692 (2002).
62. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P. & Steinman, R. M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl Acad. Sci. USA 101, 7669-7674 (2004).
63. Granelli-Piperno, A., Shimeliovich, I., Pack, M., Trumpfheller, C. & Steinman, R. M. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J. Immunol. 176, 991-998 (2006).
64. Fidler, S. J. et al. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Immunology 89, 46-53 (1996).
65. Sapp, M. et al. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol. Lett. 66, 121-128 (1999).
66. Messmer, D. et al. Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells. J. Immunol. 169, 4172-4182 (2002).
67. Izmailova, E. et al. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nature Med. 9, 191-197 (2003).
68. Fanales-Belasio, E. et al. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J. Immunol. 168, 197-206 (2002).
69. + T cell activation. Exp. Cell Res. 275, 243-254 (2002).
70. + T lymphocytes. AIDS Res. Hum. Retroviruses 17, 1365-1370 (2001).
71. Shinya, E. et al. Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells. Virology 326, 79-89 (2004).
72. Spira, A. I. et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225 (1996).
73. Hu, J., Miller, C. J., O'Doherty, U., Marx, P. A. & Pope, M. The dendritic cell-T cell milieu of the lymphoid tissue of the tonsil provides a locale in which SIV can reside and propagate at chronic stages of infection. AIDS Res. Hum. Retroviruses 15, 1305-1314 (1999).
74. Hu, J., Gardner, M. B. & Miller, C. J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087-6095 (2000).
75. Hu, Q. et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199, 1065-1075 (2004).
76. Lederman, M. M., Offord, R. E. & Hartley, O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nature Rev. Immunol. 6, 371-382 (2006).
77. Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000). Characterizes the role of DC-SIGN in increasing HIV trans-infection.
78. Lin, G. et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77, 1337-1346 (2003).
79. Pohlmann, S. et al. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 75, 10523-10526 (2001).
80. Wu, L., Martin, T. D., Han, Y. C., Breun, S. K. & KewalRamani, V. N. Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology 1, 14 (2004).
81. Lee, B. et al. Cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75, 12028-12038 (2001).
82. Trumpfheller, C., Park, C. G., Finke, J., Steinman, R. M. & Granelli-Piperno, A. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int. Immunol. 15, 289-298 (2003).
83. Nobile, C., Moris, A., Porrot, F., Sol-Foulon, N. & Schwartz, O. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. J. Virol. 77, 5313-5323 (2003).
84. + dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood 100, 1780-1786 (2002).
85. + immature DCs in human rectal mucosa.
86. Wu, L. et al. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl Acad. Sci. USA 99, 1568-1573 (2002). Shows DC-SIGN-independent transmission of primate lentiviruses by rhesus macaque DCs.
87. Wu, L., Martin, T. D., Vazeux, R., Unutmaz, D. & KewalRamani, V. N. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J. Virol. 76, 5905-5914 (2002).
88. Baribaud, F., Pohlmann, S., Leslie, G., Mortari, F. & Doms, R. W. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J. Virol. 76, 9135-9142 (2002).
89. Gummuluru, S., Rogel, M., Stamatatos, L. & Emerman, M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77, 12865-12874 (2003).
90. Soilleux, E. J. et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71, 445-457 (2002).
91. Krutzik, S. R. et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nature Med. 11, 653-660 (2005).
92. Chehimi, J. et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 74, 757-763 (2003).
93. Nguyen, D. G. & Hildreth, J. E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483-493 (2003).
94. Kwon, D. S., Gregorio, G., Bitton, N., Hendrickson, W. A. & Littman, D. R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16, 135-144 (2002). Reports that HIV internalization is important for efficient DC-SIGN-mediated transmission of HIV.
95. Wu, L., Martin, T. D., Carrington, M. & KewalRamani, V. N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318, 17-23 (2004). Shows that DC-SIGN-mediated transmission of HIV is cell-type dependent and indicates that B cells and DCs that facilitate viral transmission have common features.
96. Soilleux, E. J. et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. Pathol. 195, 586-592 (2001).
97. Jameson, B. et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76, 1866-1875 (2002).
98. Engering, A. et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am. J. Pathol. 164, 1587-1595 (2004).
99. Soilleux, E. J. & Coleman, N. Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN. Blood 98, 1987-1988 (2001).
100. + T cells. J. Immunol. 155, 4111-4117 (1995).
101. Frank, I. et al. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76, 2936-2951 (2002).
102. +hematopoietic progenitor cells is primarily determined by their maturation stage. Blood 93, 3866-3875 (1999).
103. Cavrois, M. et al. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 80, 1992-1999 (2006).
104. Bakri, Y. et al. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 166, 3780-3788 (2001).
105. + T cells in response to antigen depends on close contact through adhesion molecules. Virology 239, 259-268 (1997).
106. Garcia, E. et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6, 488-501 (2005).
107. Bromley, S. K. et al. The immunological synapse. Annu. Rev. Immunol. 19, 375-396 (2001).
108. Arrighi, J. F. et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78, 10848-10855 (2004).
109. Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nature Rev. Immunol. 2, 569-579 (2002).
110. Pelchen-Matthews, A., Kramer, B. & Marsh, M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-455 (2003).
111. Nguyen, D. G., Booth, A., Gould, S. J. & Hildreth, J. E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278, 52347-52354 (2003).
112. Sharova, N., Swingler, C., Sharkey, M. & Stevenson, M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24, 2481-2489 (2005).
113. Petit, C. et al. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology 286, 225-236 (2001).
114. + T cells: HIV antigen presentation, T cell activation, viral transfer. Blood 108, 1643-1651 (2006).
115. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004).
116. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004).
117. Raposo, G. et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718-729 (2002).
118. Lu, W., Arraes, L. C., Ferreira, W. T. & Andrieu, J. M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nature Med. 10, 1359-1365 (2004). First paper to report a potential therapeutic, DC-based vaccine against chronic HIV infection.
119. Kundu, S. K. et al. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res. Hum. Retroviruses 14, 551-560 (1998).
120. Curtis, B. M., Scharnowske, S. & Watson, A. J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl Acad. Sci. USA 89, 8356-8360 (1992).
121. Rappocciolo, G. et al. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog. 2, e70 (2006). Recent report that the induction of DC-SIGN expression on activated primary B cells potentiates HIV transmission to T cells.
122. Tailleux, L. et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121-127 (2003).
123. Mitchell, D. A., Fadden, A. J. & Drickamer, K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276, 28939-28945 (2001).
124. Feinberg, H., Mitchell, D. A., Drickamer, K. & Weis, W. I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294, 2163-2166 (2001).
125. Feinberg, H., Guo, Y., Mitchell, D. A., Drickamer, K. & Weis, W. I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 280, 1327-1335 (2005).
126. Sol-Foulon, N. et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16, 145-155 (2002).
127. Pohlmann, S., Baribaud, F. & Doms, R. W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22, 643-646 (2001).
128. Ganesh, L. et al. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 78, 11980-11987 (2004).